Live Breaking News & Updates on Non Alcoholic Steatohepatitis Nash

Stay updated with breaking news from Non alcoholic steatohepatitis nash . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Resmetirom improves liver fibrosis in nonalcoholic steatohepatitis

1. In this randomized controlled trial, among patients with nonalcoholic steatohepatitis (NASH) with liver fibrosis, resmetirom was superior to placebo in improving fibrosis. 2. Diarrhea and nausea were the most common adverse events associated with resmetirom. Evidence Rating Level: 1 (Excellent) Study Rundown: NASH is a progressive liver disease associated with metabolic dysfunction characterized by ....

Minute Medicine Inc , Rating Level , Internal Medicine , Liver Fibrosis , Non Alcoholic Steatohepatitis Nash , Nonalcoholic Steatohepatitis , Chronic Disease ,